АЙХАН КАРАКОСЕ

KARAKÖSE

Istiniye University Liv Hospital – Urology Doctor 

Istiniye University, 

Assoc Doctor

• Isparta Eğirdir Mountain Commando School (Military Service) - Specialist Doctor 2010-2011
• Muş State Hospital Urology Clinic (Compulsory Service) - Specialist Doctor 2011 -2012
• Medicalpark İzmir Hospital - Specialist Doctor 2012 - 2012
• Izmir University Faculty of Medicine, Department of Urology - Assist.Prof. 2012 -2015
• Izmir University Faculty of Medicine, Department of Urology - Assoc. Dr. 2015-2016
• Medicalpark İzmir Hospital - Assoc. Dr. 2016-2017
• İzmir Ekol Hospital - Assoc. Dr. 2017-2019
• İzmir Sada Hospital -Kordon İnternational - Assoc. Dr. 2019-2020

• Uludağ University Faculty of Medicine 1998-2004
• Istanbul Fatih Sultan Mehmet Training and Research Hospital Urology Clinic 2004-2010

• The Sixth Applied Urological Laparoscopic Surgery Course and Symposium 2008

• Urological Laparoscopic and Robotic Surgery Training Bakırköy Sadi Konuk Training and Research Hospital 2010

The Pre-Congress Live Surgery Course Laparoscopic Surgery 2015

• Radiology Course 2016

Retrograde Intrarenal Surgery Course 2016

• Course Andrology: Current Identification and Risk Factors in Female Sexual Dysfunction 2016

Turkish Urology Academy Andrological Tests Update Course 2016

Certificate of Investigator Safety Training 2016

• "Randomized, Placebo-Controlled, Double-Blind Phase 3 Study in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Volunteers with Apalutamide and ADT Combination Against Androgen Deprivation Therapy (ADT), 56021927PCR3002" Other (International), Researcher, 21/02/2016

• "Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of JNJ-56021927 in Patients with High-Risk Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy, ATLAS Study protocol: 56021927PCR3003" Other (International), Date of Publication : 26/04/2017 22:30:47 Page: 5 Researcher,, 11/07/2016

• “Phase III, Multicenter, Randomized, Placebo-Controlled Trial Investigating Atezolizumab (Antipd-L1 Antibody) as Monotherapy or in Combination with Platinum-Based Chemotherapy in Patients with Untreated Local Advanced or Metastatic Urothelial Carcinoma” WO30070 ", Other (International), Researcher ,, 01/12/2016

• “Phase 3, Randomized, Controlled Clinical Study, MK3475-361, Comparing Chemotherapy versus Pembrolizumab with Platinum-Based Combination Therapy in Volunteers with Advanced or Metastatic Urothelial Carcinoma, Randomized, Controlled Clinical Study, MK3475-361” KEYNOTE-361, Other (International), Researcher, 05 / 04/2017

GCP Training Certificate 2017

• Holep Certificate Vivantes AVK Auguste-Viktoria-Hospital 2017

Training Certificate & Authorized User ED 1000 Treatment Medispec 2018

• Laparoscopic Surgery
• Prostate cancer
• Kidney Cancer
• Bladder Cancer
• Stone Disease Surgery - Flexible URS - RIRS - PNL
• Prostate Diseases - HoLEP
• Urinary Incontinence Surgeries (TOT, TVT)
• Urethral Stricture Treatment
• Microscopic Varicocele - Infertility Treatment
• Pediatric Urology